Eupraxia Pharmaceuticals Inc. (EPRX) quarterly balance sheet — complete assets, liabilities & equity history
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 | Q2'21 |
|---|
| Total Current Assets | 142.59M | 85.1M | 127.18M | 22.83M | 28.61M | 34.44M | 9.89M | 24.53M | 36.22M | 19.8M | 33.77M | 19.74M | 19.2M | 25.17M | 30.78M | 36.4M | 26.64M | 30.6M | 34.24M | 36.86M |
| Cash & Short-Term Investments | 139.34M | 80.56M | 123.95M | 19.77M | 27.45M | 33.1M | 8.66M | 23.32M | 35.91M | 19.34M | 33.21M | 19.1M | 18.83M | 24.73M | 29.98M | 35.46M | 25.9M | 29.9M | 33.67M | 36.08M |
| Cash Only | 58.69M | 80.56M | 123.95M | 19.77M | 27.45M | 33.1M | 8.66M | 23.32M | 35.91M | 19.34M | 33.21M | 19.1M | 18.83M | 24.73M | 11.8M | 17.39M | 16.88M | 20.89M | 33.67M | 36.08M |
| Short-Term Investments | 80.64M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 18.17M | 18.06M | 9.02M | 9.01M | 0 | 0 |
| Accounts Receivable | 665.42K | 674.23K | 194.94K | 134.61K | 238.53K | 228.87K | 105.93K | 155.24K | 167.24K | 190.61K | 67.84K | 0 | 0 | 0 | 0 | 376.62K | 350.15K | 0 | 0 | 0 |
| Days Sales Outstanding | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Inventory Outstanding | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Current Assets | 8.49K | 0 | 194.72K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 68.47K | 117.83K | 121.47K | 390.6K | 186.82K | 0 | 429.72K | 102.37K | 40.48K |
| Total Non-Current Assets | 3.24M | 1.05M | 1.32M | 766.17K | 626.77K | 505.68K | 474.92K | 450.13K | 420.43K | 463.15K | 577.98K | 617.01K | 659.68K | 721.98K | 666.06K | 665.36K | 557.51K | 620.44K | 672.71K | 279.92K |
| Property, Plant & Equipment | 3.18M | 987.13K | 1.18M | 688.33K | 546.54K | 424.92K | 456.49K | 445.53K | 414.85K | 456.25K | 573.77K | 611.17K | 656.84K | 718.61K | 665.38K | 664.5K | 556.48K | 589.07K | 612.41K | 279.92K |
| Fixed Asset Turnover | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 61.96K | 64.33K | 136.05K | 77.84K | 80.23K | 80.76K | 18.43K | 4.6K | 5.57K | 6.9K | 4.21K | 5.84K | 2.84K | 3.37K | 672 | 854 | 1.03K | 31.37K | 60.3K | 0 |
| Total Assets | 145.83M | 86.15M | 128.5M | 23.6M | 29.23M | 34.94M | 10.36M | 24.98M | 36.64M | 20.27M | 34.35M | 20.36M | 19.86M | 25.89M | 31.45M | 37.06M | 27.2M | 31.22M | 34.91M | 37.14M |
| Asset Turnover | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Asset Growth % | 398.86% | 146.55% | 1139.75% | -5.52% | -20.21% | 72.42% | -69.83% | 22.67% | 84.52% | -21.72% | 9.22% | -45.06% | -27% | -17.08% | -9.91% | -0.22% | -16.46% | 2047.93% | 3691.83% | - |
| Total Current Liabilities | 7.39M | 5.63M | 5.3M | 2.62M | 2.2M | 3.1M | 2.37M | 11.6M | 18.53M | 19.37M | 19.28M | 14.61M | 2.18M | 4.14M | 2.25M | 3.59M | 1.26M | 2.27M | 2.85M | 816.35K |
| Accounts Payable | 0 | 0 | 5.2M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Payables Outstanding | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Short-Term Debt | 204.18K | 0 | 0 | 0 | 0 | 0 | 0 | 4.55M | 9.52M | 10.4M | 15.33M | 11.01M | 108.92K | 107.53K | 107.25K | 163.41K | 76.03K | 94.92K | 93.98K | 0 |
| Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 6.3M | 0 | 0 | 0 | 0 | 1.49M | 0 | 0 | 550.95K | 858.63K | 1.04M | 297.93K | 292.1K | 21.66K | 279.29K | 3.35M | 1.06M | 5.01K | 13.3K | 60.25K |
| Current Ratio | 19.30x | 15.12x | 23.98x | 8.72x | 13.00x | 11.10x | 4.17x | 2.11x | 1.95x | 1.02x | 1.75x | 1.35x | 8.82x | 6.08x | 13.66x | 10.13x | 21.10x | 13.49x | 12.03x | 45.15x |
| Quick Ratio | 19.30x | 15.12x | 23.98x | 8.72x | 13.00x | 11.10x | 4.17x | 2.11x | 1.95x | 1.02x | 1.75x | 1.35x | 8.82x | 6.08x | 13.66x | 10.13x | 21.10x | 13.49x | 12.03x | 45.15x |
| Cash Conversion Cycle | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Non-Current Liabilities | 1.81M | 75.91K | 131.96K | 0 | 0 | 0 | 14.3K | 34.95K | 0 | 0 | 11.79K | 59.13K | 10.63M | 11.99M | 10.12M | 9.86M | 9.62M | 9.84M | 9.23M | 8.78M |
| Long-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 28.09K | 10.58M | 11.92M | 10.03M | 9.76M | 9.62M | 9.7M | 9.08M | 8.62M |
| Capital Lease Obligations | 1.81M | 75.91K | 131.45K | 0 | 0 | 0 | 14.3K | 34.95K | 0 | 0 | 11.79K | 31.03K | 50.2K | 69.46K | 86.55K | 103.62K | 96.67K | 137.75K | 148.38K | 168.72K |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 0 | 0 | 510 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -96.67K | 0 | 0 | 0 |
| Total Liabilities | 9.2M | 5.7M | 5.43M | 2.62M | 2.2M | 3.1M | 2.39M | 11.64M | 18.53M | 19.37M | 19.29M | 14.67M | 12.8M | 16.13M | 12.37M | 13.45M | 10.88M | 12.1M | 12.07M | 9.6M |
| Total Debt | 2.01M | 154.36K | 237.38K | 35.06K | 52.77K | 71.86K | 93.05K | 4.66M | 9.56M | 10.45M | 15.41M | 11.14M | 10.81M | 12.17M | 10.29M | 10.02M | 9.84M | 9.99M | 9.38M | 8.84M |
| Net Debt | -56.68M | -80.41M | -123.72M | -19.73M | -27.4M | -33.03M | -8.57M | -18.66M | -26.35M | -8.89M | -17.79M | -7.96M | -8.02M | -12.56M | -1.51M | -7.37M | -7.04M | -10.9M | -24.29M | -27.24M |
| Debt / Equity | 0.01x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.01x | 0.35x | 0.53x | 11.71x | 1.02x | 1.96x | 1.53x | 1.25x | 0.54x | 0.42x | 0.60x | 0.52x | 0.41x | 0.32x |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Interest Coverage | - | - | - | - | - | -54965.96x | -13283.57x | -20.53x | -18.16x | -41.30x | -13.47x | -30.50x | -12.57x | -18.47x | -14.77x | -15.99x | -10.24x | -10.24x | -14.85x | -29.38x |
| Total Equity | 136.64M | 80.45M | 123.06M | 20.98M | 27.03M | 31.84M | 7.98M | 13.34M | 18.11M | 892.33K | 15.06M | 5.69M | 7.05M | 9.76M | 19.08M | 23.61M | 16.32M | 19.12M | 22.84M | 27.54M |
| Equity Growth % | 405.44% | 152.67% | 1442.56% | 57.28% | 49.3% | 3468.09% | -47.03% | 134.23% | 156.79% | -90.86% | -21.06% | -75.88% | -56.79% | -48.95% | -16.44% | -14.28% | -33.98% | 188.25% | 204.59% | - |
| Book Value per Share | 2.41 | 1.55 | 3.33 | 0.58 | 0.76 | 0.89 | 0.22 | 0.37 | 0.63 | 0.04 | 0.55 | 0.26 | 0.32 | 0.45 | 0.89 | 1.19 | 1.15 | 1.54 | 1.60 | 2.08 |
| Total Shareholders' Equity | 138.24M | 82.04M | 125.27M | 22.55M | 28.6M | 33.4M | 9.52M | 14.83M | 19.54M | 2.22M | 17.04M | 7.44M | 8.62M | 10.54M | 20.31M | 24.7M | 17.22M | 19.95M | 23.61M | 28.16M |
| Common Stock | 256.34M | 195.41M | 265.79M | 117.12M | 116.84M | 116.36M | 116.32M | 116.32M | 116.32M | 92.91M | 118.05M | 99.41M | 92.59M | 96.13M | 91.87M | 91.87M | 80.71M | 77.65M | 80.76M | 80.76M |
| Retained Earnings | -182.83M | -169.58M | -212.71M | -146.51M | -137.77M | -131M | -123.49M | -117.55M | -111.54M | -105.5M | -122.7M | -110.28M | -102.29M | -104.63M | -88.62M | -83.97M | -77.88M | -74.26M | -70.47M | -65.49M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | -4.5M | -2.04M | -4.59M | -2.79M | -4.12M | -4.16M | -2.79M | -2.92M | -2.74M | -2.71M | 0 | 1 | -1 | -3.77M | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | -1.6M | -1.6M | -2.21M | -1.58M | -1.57M | -1.57M | -1.54M | -1.49M | -1.44M | -1.32M | -1.98M | -1.75M | -1.57M | -783.49K | -1.23M | -1.09M | -902.6K | -833.84K | -774.54K | -613.75K |